1.
Wagg A, Franks B, Ramos B, Berner T. Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada. CUAJ [Internet]. 2015Oct.13 [cited 2021May17];9(9-10):343-50. Available from: https://cuaj.ca/index.php/journal/article/view/3098